ARTICLE | Clinical News
Velcade bortezomib regulatory update
August 30, 2010 7:00 AM UTC
The U.K.'s NICE issued a final appraisal determination (FAD) related to use of thalidomide from Celgene Corp. (NASDAQ:CELG, Summit, N.J.) and Velcade bortezomib from Johnson & Johnson to treat multip...